ASM-024
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ASM-024, covering 2012-01-26 to 2015-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma [Phase 1, Phase 2]